Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY19 is not expected to be complete until June, 2020.

  1. Promoting Responsible Drinking: An Internet-based, Interactive Computer Tailored Intervention

    SBC: Pro-Change Behavior Systems Inc            Topic: NIAAA

    DESCRIPTION provided by applicant Excessive alcohol use is associated with a range of serious and costly health social and economic consequences at the individual and societal level This program of research serves as a venue by which to produce and test an innovative science based and cost effective means to intervene in a private convenient and individualized way with employed adults wh ...

    SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
  2. IGF OT IGF A STAGE BASED MOBILE INTERVENTION FOR SUBSTANCE USE DISORDERS IN PRIMARY CARE N DA POP SEPTEMBER FEBRUARY BASE AWARD

    SBC: Pro-Change Behavior Systems Inc            Topic: NIDA

    Not Available

    SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
  3. IGF OT IGF DEVELOPMENT and CHARACTERIZATION FDA COMPLIANT ELECTRONIC VAPOR BASED COMBINATION PRODUCT POP N DA SBIR I BASE AWARD

    SBC: WHAT A SMOKE L.L.C.            Topic: NIDA

    Not Available

    SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
  4. IGF OT IGF VALIDATION OF MOBILE TECHNOLOGIES FOR CLINICAL ASSESSMENT

    SBC: Pro-Change Behavior Systems Inc            Topic: NCI

    Not Available

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
  5. IGF OT IGF FY IWIN NAVIGATING YOUR PATH TO WELL BEING SBIR PHASE II BASE AWARD PERIOD OF PERFORMANCE

    SBC: Pro-Change Behavior Systems Inc            Topic: NIDA

    Not Available

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
  6. Vulnerable Plaque Amplified Optical Analyzer

    SBC: Energy Research Company            Topic: NHLBI

    DESCRIPTION provided by applicant Energy Research Company ERCo in a collaboration with The City College of New York CCNY and Columbia University Medical Center CUMC proposes developing the Vulnerable Plaque Amplified Optical Analyzer VPAOA a fiber optic catheter instrument based on patented amplified spectroscopy technology for detecting and analyzing vulnerable plaque VP in corona ...

    STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
  7. Interactive technology for media literacy drug prevention in community groups

    SBC: Real Prevention LLC            Topic: R41

    DESCRIPTION provided by applicant The goal of this STTR R proposal is to transfer the technology from Rutgers University to REAL Prevention needed to adapt a substance use prevention media literacy curriculum for web based delivery in community organizations for commercialization Substance use increases in frequency and risk through mid adolescence yet most prevention interventions target ...

    STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
  8. A method for the determination of the percentage of CD4 T cells and CD4/CD8 ratio

    SBC: Allied Innovative Systems LLC            Topic: NIAID

    DESCRIPTION provided by applicant The long term goal of the proposed research is to develop a simple quantitative point of care POC method for determination of percentage of circulating CD T lymphocytes and CD CD ratio in blood of pediatric patients CD cell counts are needed to stage and monitor HIV infected patients In adults the absolute number of CD T cells per microlitre of bloo ...

    SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
  9. Non-Immunosuppressive Cyclosporine Analogs for Novel Antifungal Therapies

    SBC: SCYNEXIS, INC.            Topic: NIAID

    DESCRIPTION provided by applicant Due to poor outcomes of patients with invasive fungal infections and expensive health care needs of these patients invasive fungal infections carry exceedingly high human and financial costs The cost of invasive fungal infections to the healthcare system is conservatively estimated to be $ billion annually in the US alone Current antifungal agents can hav ...

    SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
  10. Point-of-care immunoassay for early diagnosis of pertussis

    SBC: DxDiscovery Incorporated            Topic: NIAID

    DESCRIPTION provided by applicant Pertussis is a serious and potentially life threatening respiratory disease caused by the bacterium Bordetella pertussis Worldwide million people become ill with pertussis each year and of these patients die Despite high vaccine coverage in the United States there were still over pertussis cases reported in the U S in Rapid diagn ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government